US Edition
Published • loading... • Updated
University of Toronto - GLP-1 Medicine Improves Liver Health Independent of Weight Loss: Study
Summary by Education News Canada
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Now, a study conducted between the University of Toronto and the Center for Research in Molecular Medicine (both in Canada), and published in Cell Metabolism, shows that semaglutide exerts direct effects on the liver, regardless of fat loss, and reveals its efficacy against metabolic liver disease. Specifically, this research shows that the GLP-1 receptor – the therapeutic target of semaglutide – is found in a very specific type of liver endothe…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
